Journal of Infertility and Reproductive Biology
ISSN: 2310-7588
The latest research in infertility and reproductive medicine from across the world
The Role of Genomic Instability in Unexplained Infertility: An Overview
Published date: Jun 20 2025
Journal Title: Journal of Infertility and Reproductive Biology
Issue title: Journal of Infertility and Reproductive Biology: Volume 13, Issue 2
Pages: 89 - 96
Authors:
Abstract:
Unexplained infertility (UI) is an ambiguous condition that afflicts a significant number of couples around the world, despite normal findings in routine infertility tests. This review examines the role of DNA damage, especially in spermatozoa, as a potential cause of unexplained infertility. Sperm DNA fragmentation (SDF), often not detected in conventional sperm analysis, has emerged as a key biomarker for assessing male fertility potential. Elevated DNA fragmentation index (DNA) levels, caused primarily by oxidative stress, environmental toxins and incorrect chromatin remodelling, have been associated with poor reproductive performance, including miscarriage and Assisted Reproductive Technologies (ART). In addition, subclinical factors in women, such as early-stage endometriosis or luteal phase defects, may contribute to the diagnosis of uterine fibrosis. Advanced diagnostic techniques such as Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL), Sperm Chromatin Structure Assay (SCSA) and Comet Assay offer more accurate detection of DNA damage. An understanding of these molecular factors is essential for specific treatment strategies and to improve the success rate of both natural and artificial insemination.
Keywords: unexplained infertility, DNA damage, sperm DNA fragmentation, oxidative stress, DNA fragmentation Index, assisted reproductive technologies
References:
[1] Kumari KRA, L S. A study on Profile of patients attending infertility clinic. PRC Report 2018-3; 2018.
[2] Wang Q, Gu X, Chen Y, Yu M, Peng L, Zhong S, et al. The effect of sperm DNA fragmentation on in vitro fertilization outcomes of unexplained infertility. Clinics. 2023; 78:100261.
[3] Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, et al. Population study of causes, treatment, and outcome of infertility. BMJ. 1985 ;291(6510):1693–7.
[4] Chakarov S, Petkova R, Russev GC, Zhelev N. DNA damage and mutation. Types of DNA damage. Bio Discovery. 2014; 11:e8957.
[5] Velando A, Noguera JC, Silva A, Kim SY. Redox-regulation and life-history trade-offs: scavenging mitochondrial ROS improves growth in a wild bird. Sci Rep. 2019; 9:2203.
[6] Morrow S, Guille M, Holt W, Garner T. The impact of DNA damage induced by sperm cryopreservation in Xenopus. Reprod Abstr. 2014. doi:10.1530/repabs.1.p365.
[7] Maner BS, Dupuis L, Su A, Jueng JJ, Harding TP, Meisenheimer J, et al. Overview of genetic signaling pathway interactions within cutaneous malignancies. J Cancer Metastasis Treat. 2020; 6:37.
[8] Gelbaya TA, Potdar N, Jeve YB, Nardo LG. Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv. 2014;69(2):109–15.
[9] Tandulwadkar S, Babar SR, Mishra S, Gupta S. Prevalence and clinical utility of sperm DNA fragmentation index in couples with unexplained infertility. Int J Reprod Contracept Obstet Gynecol. 2022;11(6):1679.
[10] Zhu C, Zhang S, Chen F, She H, Ju Y, Wen X, et al. Correlations between elevated basal sperm DNA fragmentation and the clinical outcomes in women undergoing IUI. Front Endocrinol (Lausanne). 2022; 13:987812.
[11] Henkel R. TUNEL Assay and SCSA. In: Andreescu S, Henkel R, Khelfi A, editors. Biomarkers of Oxidative Stress. Cham: Springer. 2024; 497–50.
[12] Agarwal A, Farkouh A, Parekh N, Zini A, Arafa M, Kandil H, et al. Sperm DNA fragmentation: a critical assessment of clinical practice guidelines. World J Mens Health. 2022;40(1):30–7.
[13] Hamad M. Protamines and DNA integrity as biomarkers of sperm quality of smokers and nonsmokers patients undergoing assisted reproduction therapy [doctoral thesis]. 2009.
[14] Agarwal A. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum Reprod Update. 2003;9(4):331–45.
[15] Kumaraguruparan R, Kabalimoorthy J, Nagini S. Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem. 2005;38(2):154–8.
[16] La Marca A, Mastellari E. Infertility. In: Petraglia F, Fauser BC, editors. Female Reproductive Dysfunction. Springer Cham; 2020; 211–33.
[17] Smits RM, Mackenzie-Proctor R, Yazdani A, Stankiewicz MT, Jordan V, Showell MG. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2019; 3:CD007411.
[18] Baldi E, Colpi GM, Huang ZW, Balagobi B, Boitrelle F, Shah R, et al. High sperm DNA fragmentation – finding a needle in the haystack: tips on selecting the best sperm for ICSI and ART. Asian J Androl. 2025;27(2):139–43.
[19] Gharagozloo P, Aitken RJ. The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Hum Reprod. 2011; 26(7):1628–40.
[20] Evenson DP. Sperm Chromatin Structure Assay (SCSA®): Evolution from Origin to Clinical Utility. In: Zini A, Agarwal A, editors. A Clinician’s Guide to Sperm DNA and Chromatin Damage. Springer Cham. 2018; 65–89.